Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study
- PMID: 8462885
- DOI: 10.1007/BF00920936
Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study
Abstract
Forty patients with late-onset diabetes (age at diagnosis 30 years or more) and minimal retinopathy as found by fundus photography were followed prospectively by repeated examination (baseline, 1 year, and 4 years). The study shows that early retinopathy changes are not permanent or invariably progressive. In the 1st year of follow-up microaneurysms worsened in 25%, improved in 10%, and remained stabilized in 65%. Vitreous fluorometry was able to detect an overall increase of 0.84 +/- 1.06 x 10(-6) min-1 in blood-retinal barrier (BRB) penetration ratios. After 4 years, 16 of the 40 patients had undergone photocoagulation (focal photo-coagulation in 11 and pan retinal photocoagulation in 5). The eyes that needed photocoagulation were the eyes that had higher fluorometry penetration ratios at the patient's entry into the study and showed a higher rate of deterioration during the 1st year of the study (5.54 +/- 1.97 vs 3.11 +/- 1.22 x 10(-6) min-1, P < 0.001, initial values; 1.52 +/- 0.76 vs 0.45 +/- 0.99 x 10(-6) min-1, P < 0.001, annual increase in leakage). The eyes that did not need photocoagulation, 24 out of 40, showed stable fluorometry readings within the 4-year period of follow-up (+0.02 +/- 0.98 10(-6) min-1). Abnormally high vitreous fluorometry values and their rapid increase over time appear to be good indicators of rapid progression and worsening of the retinopathy.
Similar articles
-
Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study.Graefes Arch Clin Exp Ophthalmol. 1998 Apr;236(4):264-8. doi: 10.1007/s004170050075. Graefes Arch Clin Exp Ophthalmol. 1998. PMID: 9561358
-
Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.Invest Ophthalmol Vis Sci. 2007 Sep;48(9):3983-7. doi: 10.1167/iovs.06-1102. Invest Ophthalmol Vis Sci. 2007. PMID: 17724176
-
Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.Arch Ophthalmol. 2004 Feb;122(2):211-7. doi: 10.1001/archopht.122.2.211. Arch Ophthalmol. 2004. PMID: 14769598
-
Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes.Diabetes. 1983 May;32 Suppl 2:20-7. doi: 10.2337/diab.32.2.s20. Diabetes. 1983. PMID: 6400666 Review.
-
Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.Acta Ophthalmol Suppl (1985). 1993;(211):1-52. Acta Ophthalmol Suppl (1985). 1993. PMID: 8318868 Review.
Cited by
-
Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.Graefes Arch Clin Exp Ophthalmol. 1996 Apr;234(4):246-50. doi: 10.1007/BF00430417. Graefes Arch Clin Exp Ophthalmol. 1996. PMID: 8964530
-
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1591-600. doi: 10.1007/s00417-006-0318-2. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16763797 Clinical Trial.
-
The Role of Retinal Pigment Epithelial Cells in Regulation of Macrophages/Microglial Cells in Retinal Immunobiology.Front Immunol. 2021 Aug 13;12:724601. doi: 10.3389/fimmu.2021.724601. eCollection 2021. Front Immunol. 2021. PMID: 34484232 Free PMC article. Review.
-
Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):639-46. doi: 10.1007/BF00946940. Graefes Arch Clin Exp Ophthalmol. 1997. PMID: 9349948
-
Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury.Neurochem Res. 1999 Mar;24(3):351-8. doi: 10.1023/a:1020977331372. Neurochem Res. 1999. PMID: 10215508
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous